Conference Call and Webcast to Follow
ROCKVILLE, Md., Oct. 30 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the quarter ended September 30, 2007, on Thursday, November 8, 2007, before the market opens. A full text copy of the release will be disseminated at that time.
Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results and other corporate developments at 10:30 AM ET on Thursday, November 8, 2007. Also participating on the call will be Steven A. Shallcross, Senior Vice President and CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:30 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.
The teleconference dial-in numbers are as follows:
Domestic callers 1-866-578-5801
International callers 1-617-213-8058
The conference call will be broadcast simultaneously and archived on the Company's Web site, http://www.vandapharma.com. Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, November 8, 2007,
beginning at 12:30 PM ET and will be accessible until Thursday, November
15, 2007, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for
domestic callers and 1-617-801-6888 for international callers. The access
|SOURCE Vanda Pharmaceuticals Inc.|
Copyright©2007 PR Newswire.
All rights reserved